Understanding Eyelid Tumors

The eyelid is one of the most common sites for skin tumors because it is chronically exposed to ultraviolet radiation and has thin, delicate skin. Tumors may arise from the epidermis, dermis, glands, or deeper tissues. While many eyelid lesions are benign, any new or changing growth should be evaluated to rule out malignancy.

Benign Eyelid Tumors

Common benign eyelid growths include:

• Papillomas: Skin-colored or pigmented pedunculated growths, often related to sun exposure or human papillomavirus.
• Seborrheic keratoses: Well-demarcated, waxy, stuck-on appearing lesions that increase with age.
• Epidermal inclusion cysts: Firm, round subcutaneous nodules arising from trapped keratin.
• Hidrocystomas: Translucent cystic lesions originating from sweat glands along the lid margin.
• Xanthelasma: Yellowish lipid deposits in the medial eyelid skin, sometimes associated with hyperlipidemia.

Benign lesions may be observed if asymptomatic, or excised for functional or cosmetic reasons.

Malignant Eyelid Tumors

Basal cell carcinoma (BCC)

The most common eyelid malignancy, representing roughly 85-90 percent of cases. BCC typically presents as a painless, pearly nodule with telangiectatic vessels and may ulcerate centrally. It grows slowly and rarely metastasizes but can be locally destructive if untreated, eroding into the orbit.

Squamous cell carcinoma (SCC)

Less common than BCC but more aggressive. SCC may present as a scaly, indurated plaque or nodule with irregular borders. It carries a higher risk of local invasion and regional lymph node metastasis compared to BCC.

Sebaceous gland carcinoma

Arises from the meibomian glands or glands of Zeis. Often mimics a chronic chalazion or blepharitis, leading to delayed diagnosis. It can spread along the conjunctival surface (pagetoid spread) and has a significant metastatic potential.

Melanoma

Eyelid melanoma is rare but carries the most serious prognosis. It may present as a pigmented, irregularly bordered lesion with changes in color, size, or shape. Early detection and complete excision are critical.

Diagnosis

1. Clinical examination: Assessment of the lesion's size, shape, borders, color, vascularity, and effect on surrounding structures including eyelashes and lid margin.
2. Incisional or excisional biopsy: Tissue sampling for histopathological examination is the gold standard for definitive diagnosis.
3. Frozen-section or Mohs surgery: Used to confirm clear surgical margins during excision of malignant tumors.
4. Imaging: CT or MRI may be ordered when orbital or deeper tissue invasion is suspected.

Surgical Treatment

Complete excision with histologically confirmed clear margins is the standard of care for malignant eyelid tumors. The approach depends on the tumor type, size, and location:

Excision with margin control

The tumor is excised with a safety margin of healthy tissue. The margins are examined by a pathologist (permanent sections or frozen sections) to ensure the tumor has been fully removed.

Eyelid reconstruction

After excision, the resulting defect is reconstructed using techniques tailored to its size and depth. Small defects may be closed directly. Larger defects may require local flaps (such as a Tenzel semicircular flap), lid-sharing procedures (such as a Hughes tarsoconjunctival flap for the lower lid), or free grafts of skin, cartilage, or mucous membrane.

Recovery